Current Investment Opportunities
Professor Rory Shaw, Medical Director, Healthcare UK, UKTI
1
Presentation title - edit in the Master slide
1
Cambridge Biomedical Campus
Opportunity
Innovation Centre housing 50
bio medical R&D SMEs
Investment
needed
£30m
•
Investor
rationale
Here today:
•
•
•
Ownership and naming
rights to building
£1.5m p.a. net income
Access to world leading
medical research hub
Supporting the discovery and
development of pioneering,
commercial biomedical
research
Mug
shot
[James Dancy
UKTI]
2
Manchester Centre for Cancer Biomarker Sciences
Opportunity
Research centre for personalised
medicine
Investment
needed
£35m
•
•
Investor
rationale
Here today:
•
•
Partnering and collaboration
with Manchester Cancer
Research Centre
Opportunity to invest in spinouts
Flexibility of focus on investor
research interests
Training and development
opportunities
Mug
shot
Peter Trainer
3
University College London Hospitals (UCLH) – Proton Beam Therapy
Opportunity
UCLH private PBT facility
Investment
needed
£20-30m
•
Investor
rationale
•
•
•
Here today:
Partnership in a professionally
managed private PBT facility
Commercial return from facility
Potential to leverage wider UCLH
facilities and capabilities including
3 other PBT rooms funded by DoH
Relationship with industry leading
university hospital
Mug
shot
[James Dancy UKTI]
4
King’s Futures – Innovation and Translation
Here today:
Mug
shot
Opportunity
1) New Health Innovation &
Translation Centre as well as
2) Student Housing Development
Investment
needed
£235 million
Investor
rationale
• Focus on global health challenges;
including, obesity, diabetes,
dental decay, cardiovascular
disease (CVD), AIDS.
• Blended RoI on both elements
• Financial returns on new health
treatments (spin-outs & licences)
• Secure return on London housing
• Societal returns tailored to
investor
Professor Nigel Pitts
5
University of Dundee – DRIVE
Opportunity
Dundee Research & Infrastructure
Venture is an investment
proposition in the commercial
exploitation of drug discovery
innovation combined with revenue
bearing infrastructure assets, both
from the University of Dundee.
Investment
needed
£70 million
1
•
•
Here today:
Mug
shot
Neil Crabb
Investor
rationale
•
Fund IRR of 16.4%.
Fund drawn down over 10
years and investors will take an
80% share of out-licencing
returns.
£35M property loan
component will be included in
the DRIVE package with a fixed
rate of interest of 4.5%.
6
Edinburgh BioQuarter
Opportunity
Co-location of commercial activity
alongside world class academic , clinical
research and state-of-the-art 900-bed
teaching hospital creates the opportunity
to increase innovation, collaboration,
entrepreneurship and commercialisation.
Investment
needed
£250m in total
•
Here today:
•
Mug
shot
•
•
Investor
rationale
Fiona Jefferson
•
Accommodation for 6,000 jobs on site
by year 25
>£50m industry collaborations secured
to date
Pipeline of spin out companies
Development and growth of expertise
in:
- Translational medicine
- Regenerative medicine
- Healthcare informatics and
personalised medicine
100 acre development site
7
National Centre for Ageing Science and Innovation
Opportunity
Outline
Investment on the Campus for
Ageing and Vitality in Newcastle
upon Tyne
Investment
needed
£20m - £100m
•
•
Here today:
Investor
rationale
•
Mike Morgan
Centre announced by the
Chancellor in 2014,
The Campus is a globally
unique, integrated
environment where worldclass scientific, medical, social
and technological solutions
are being forged to address
the needs and opportunities
of an ageing population.
Gaining first mover advantage
in this growing market can
expect to see significant
return on investment.
8
Lancaster University – Health Innovation Campus
Here today:
Dion Williams
Director Enterprise & Innovation
Opportunity
Outline
A campus providing for the highest
quality research, education and
innovation where University,
health and social care providers
and businesses work together
Investment
needed
£10m
Investor
rationale
• Help Saudi businesses
understand the needs of the UK
health system. e.g. through a
series of placements.
• Developing ‘early knowhow’ in
the field of potential innovations
to support ageing populations
• Training opportunities for clinical
staff from Saudi.
• Providing a ‘model’ that can be
applied in Saudi.
9
UK Fund Catalysing Dementia Research
This is not a statement of government policy
Opportunity
Outline
Fund investing in research into the
causes and treatment of dementia.
The fund aims to involve major
corporate partners and leading
research institutes.
Investment
needed
£100-120m. Requirement can be
discussed
•
Here today:
Image
[James Dancy UKTI]
•
Investor
rationale
•
Opportunity to invest alongside
UK Government and multinational healthcare
companies.
Dementia affects an estimated
44 million people worldwide, a
figure set almost to double
every 20 years as populations
age in many countries.
The focus of this fund will
accelerate our understanding
and treatment of this disease.
10
Thank you and please get in touch
Professor Rory Shaw, Medical Director, Healthcare UK, UKTI
Rory.Shaw@uktispecialist.com
James Dancy, Head of Science and Innovation, UKTI
James.Dancy@ukti.gsi.gov.uk
11